Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)

View ORCID ProfileDavid A. Jolliffe, Hayley Holt, Matthew Greenig, View ORCID ProfileMohammad Talaei, Natalia Perdek, Paul Pfeffer, Sheena Maltby, View ORCID ProfileJane Symons, Nicola L. Barlow, Alexa Normandale, Rajvinder Garcha, View ORCID ProfileAlex G. Richter, View ORCID ProfileSian E. Faustini, Christopher Orton, David Ford, View ORCID ProfileRonan A. Lyons, View ORCID ProfileGwyneth A. Davies, View ORCID ProfileFrank Kee, Christopher J. Griffiths, John Norrie, View ORCID ProfileAziz Sheikh, View ORCID ProfileSeif O. Shaheen, Clare Relton, View ORCID ProfileAdrian R. Martineau
doi: https://doi.org/10.1101/2022.03.22.22271707
David A. Jolliffe
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David A. Jolliffe
  • For correspondence: d.a.jolliffe@qmul.ac.uk a.martineau@qmul.ac.uk
Hayley Holt
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
2Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Greenig
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Talaei
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohammad Talaei
Natalia Perdek
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Pfeffer
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sheena Maltby
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane Symons
3Jane Symons Media, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jane Symons
Nicola L. Barlow
4Clinical Biochemistry Department, Black Country Pathology Services, City Hospital, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexa Normandale
4Clinical Biochemistry Department, Black Country Pathology Services, City Hospital, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajvinder Garcha
4Clinical Biochemistry Department, Black Country Pathology Services, City Hospital, Birmingham, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex G. Richter
5Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alex G. Richter
Sian E. Faustini
5Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sian E. Faustini
Christopher Orton
6Population Data Science, Swansea University Medical School, Singleton Park, Swansea, U.K.
7Health Data Research UK BREATHE Hub, Swansea University, Swansea, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Ford
6Population Data Science, Swansea University Medical School, Singleton Park, Swansea, U.K.
7Health Data Research UK BREATHE Hub, Swansea University, Swansea, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronan A. Lyons
6Population Data Science, Swansea University Medical School, Singleton Park, Swansea, U.K.
7Health Data Research UK BREATHE Hub, Swansea University, Swansea, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ronan A. Lyons
Gwyneth A. Davies
2Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, U.K.
6Population Data Science, Swansea University Medical School, Singleton Park, Swansea, U.K.
7Health Data Research UK BREATHE Hub, Swansea University, Swansea, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gwyneth A. Davies
Frank Kee
8Centre for Public Health (NI), Queen’s University Belfast, Belfast, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Frank Kee
Christopher J. Griffiths
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
2Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, U.K.
9Health Data Research UK BREATHE Hub, Queen Mary University of London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Norrie
10Usher Institute, University of Edinburgh, Edinburgh, U.K.
11Health Data Research UK BREATHE Hub, University of Edinburgh, Edinburgh, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aziz Sheikh
2Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, U.K.
10Usher Institute, University of Edinburgh, Edinburgh, U.K.
11Health Data Research UK BREATHE Hub, University of Edinburgh, Edinburgh, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aziz Sheikh
Seif O. Shaheen
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seif O. Shaheen
Clare Relton
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian R. Martineau
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.
2Asthma UK Centre for Applied Research, University of Edinburgh, Edinburgh, U.K.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adrian R. Martineau
  • For correspondence: d.a.jolliffe@qmul.ac.uk a.martineau@qmul.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

BACKGROUND Vitamin D metabolites support innate immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory pathogens. Randomized controlled trials of vitamin D to prevent coronavirus disease 2019 (Covid-19) have not yet reported.

METHODS We randomly assigned 6200 U.K. adults to receive an offer of a postal finger-prick 25-hydroxyvitamin D (25[OH]D) test with provision of a 6-month supply of higher-dose vitamin D (3200 IU/d, n=1550) or lower-dose vitamin D (800 IU/d, n=1550) to those with blood 25(OH)D concentration <75 nmol/L, vs. no offer of testing or supplementation (n=3100). The primary outcome was the proportion of participants experiencing at least one swab test- or doctor-confirmed acute respiratory infection (ARI) of any cause at six months. Secondary outcomes included incidence of swab test-confirmed Covid-19.

RESULTS Of 3100 participants offered testing, 2958 (95.4%) accepted, and 2690 (86.8%) had 25(OH)D <75 nmol/L and were sent vitamin D supplements (1356 higher-dose, 1334 lower-dose). 76 (5.0%) vs. 87 (5.7%) vs. 136 (4.6%) participants in higher-dose vs. lower-dose vs. no-offer groups experienced at least one ARI of any cause (odds ratio [OR] for higher-dose vs. no-offer 1.09, 95% CI 0.82-1.46; lower-dose vs. no-offer 1.26, 0.96-1.66). 45 (3.0%) vs. 55 (3.6%) vs. 78 (2.6%) participants in higher-dose vs. lower-dose vs. no-offer groups developed Covid-19 (OR for higher-dose vs. no-offer 1.13, 0.78-1.63; lower-dose vs. no-offer 1.39, 0.98-1.97).

CONCLUSIONS Among adults with a high baseline prevalence of vitamin D insufficiency, implementation of a test-and-treat approach to vitamin D replacement did not reduce risk of all-cause ARI or Covid-19.

TRIAL REGISTRATION ClinicalTrials.gov no. NCT04579640

Competing Interest Statement

The CORONAVIT trial was supported by the following entities who manufacture or distribute vitamin D supplements and/or vitamin D-fortified foods: Pharma Nord Ltd, DSM Nutritional Products Ltd, Synergy Biologics Ltd, Cytoplan Ltd, Thornton & Ross Ltd, Warburtons Ltd, and Hyphens Pharma Ltd. ARM declares receipt of support from Abiogen Pharma Ltd and Pharma Nord Ltd to attend meetings and/or travel.

Clinical Trial

NCT04579640

Funding Statement

This study was supported by Barts Charity (ref. MGU0459), Pharma Nord Ltd, the Fischer Family Foundation, DSM Nutritional Products Ltd, the Exilarchs Foundation, the Karl R Pfleger Foundation, the AIM Foundation, Synergy Biologics Ltd, Cytoplan Ltd, the UK National Institute for Health Research Clinical Research Network, the HDR UK BREATHE Hub, Thornton & Ross Ltd, Warburtons Ltd, Mr Matthew Isaacs (personal donation), and Hyphens Pharma Ltd.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The trial was approved by the Queens Square Research Ethics Committee, London, U.K. (ref 20/HRA/5095)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Anonymised data will be provided on reasonable request to a.martineau{at}qmul.ac.uk subject to the terms of ethical approval and Sponsor requirements.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 23, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)
David A. Jolliffe, Hayley Holt, Matthew Greenig, Mohammad Talaei, Natalia Perdek, Paul Pfeffer, Sheena Maltby, Jane Symons, Nicola L. Barlow, Alexa Normandale, Rajvinder Garcha, Alex G. Richter, Sian E. Faustini, Christopher Orton, David Ford, Ronan A. Lyons, Gwyneth A. Davies, Frank Kee, Christopher J. Griffiths, John Norrie, Aziz Sheikh, Seif O. Shaheen, Clare Relton, Adrian R. Martineau
medRxiv 2022.03.22.22271707; doi: https://doi.org/10.1101/2022.03.22.22271707
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Vitamin D Supplements for Prevention of Covid-19 or other Acute Respiratory Infections: a Phase 3 Randomized Controlled Trial (CORONAVIT)
David A. Jolliffe, Hayley Holt, Matthew Greenig, Mohammad Talaei, Natalia Perdek, Paul Pfeffer, Sheena Maltby, Jane Symons, Nicola L. Barlow, Alexa Normandale, Rajvinder Garcha, Alex G. Richter, Sian E. Faustini, Christopher Orton, David Ford, Ronan A. Lyons, Gwyneth A. Davies, Frank Kee, Christopher J. Griffiths, John Norrie, Aziz Sheikh, Seif O. Shaheen, Clare Relton, Adrian R. Martineau
medRxiv 2022.03.22.22271707; doi: https://doi.org/10.1101/2022.03.22.22271707

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (858)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8561)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1242)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10299)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1677)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (113)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (252)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1768)
  • Public and Global Health (3837)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (167)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)